Ronald W. Penczek's most recent trade in Elevance Health Inc was a trade of 443 Common Stock done at an average price of $415.1 . Disclosure was reported to the exchange on March 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health | Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 415.13 per share. | 10 Mar 2025 | 443 | 1,847 (0%) | 0% | 415.1 | 183,903 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 1,081 | 1,081 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 421 | 2,290 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 285 | 1,869 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 198 | 1,584 (0%) | 0% | 395.5 | 78,309 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 504.58 per share. | 06 Mar 2024 | 916 | 1,764 (0%) | 0% | 504.6 | 462,195 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,046 | 2,680 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 867 | 867 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 383 | 1,408 (0%) | 0% | 499.1 | 191,159 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 226 | 1,634 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 475.17 per share. | 30 Nov 2023 | 1,055 | 1,787 (0%) | 0% | 475.2 | 501,304 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 454.34 per share. | 24 Oct 2023 | 64 | 2,842 (0%) | 0% | 454.3 | 29,078 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,195 | 3,262 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 819 | 819 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 380 | 2,882 (0%) | 0% | 468.8 | 178,136 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 214 | 2,067 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 64 | 1,853 (0%) | 0% | 469.0 | 30,018 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 463.68 per share. | 01 Mar 2022 | 2,423 | 1,902 (0%) | 0% | 463.7 | 1,123,497 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 953 | 2,818 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 882 | 882 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 271.27 per share. | 01 Mar 2022 | 653 | 3,857 (0%) | 0% | 271.3 | 177,139 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 653 | 654 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 307.68 per share. | 01 Mar 2022 | 468 | 4,325 (0%) | 0% | 307.7 | 143,994 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 468 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 311.48 per share. | 01 Mar 2022 | 438 | 3,204 (0%) | 0% | 311.5 | 136,428 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 438 | 877 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 369 | 1,643 (0%) | 0% | 451.5 | 166,604 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 222 | 1,865 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.48 per share. | 01 Mar 2022 | 52 | 2,766 (0%) | 0% | 463.5 | 24,101 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Sale of securities on an exchange or to another person at price $ 453.48 per share. | 07 Feb 2022 | 2,763 | 2,012 (0%) | 0% | 453.5 | 1,252,965 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 935 | 468 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 307.68 per share. | 07 Feb 2022 | 935 | 3,765 (0%) | 0% | 307.7 | 287,681 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 232.04 per share. | 07 Feb 2022 | 818 | 2,830 (0%) | 0% | 232.0 | 189,809 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 818 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 653 | 1,307 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 271.27 per share. | 07 Feb 2022 | 653 | 4,775 (0%) | 0% | 271.3 | 177,139 | Common Stock |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 357 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 07 Feb 2022 | 357 | 4,122 (0%) | 0% | 167.0 | 59,608 | Common Stock |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 333.94 per share. | 05 Mar 2021 | 2,068 | 3,137 (0%) | 0% | 333.9 | 690,588 | Common Stock |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 323.57 per share. | 04 Mar 2021 | 67 | 5,205 (0%) | 0% | 323.6 | 21,679 | Common Stock |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,573 | 5,314 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 1,315 | 1,315 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 818 | 2,419 (0%) | 0% | 311.5 | 254,791 | Common Stock |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 322 | 2,741 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.67 per share. | 01 Mar 2021 | 42 | 5,272 (0%) | 0% | 311.7 | 13,090 | Common Stock |
| Elevance Health | Ronald W. Penczek | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 330.75 per share. | 09 Nov 2020 | 1,199 | 3,229 (0%) | 0% | 330.7 | 396,569 | Common Stock |